Zobrazeno 1 - 10
of 18
pro vyhledávání: '"A D, Tahanovich"'
Publikováno v:
Медицинская иммунология, Vol 25, Iss 2, Pp 309-318 (2023)
Currently, no drugs have been identified that could slow progression of chronic obstructive pulmonary disease (COPD), or have a significant impact on patient mortality. Therefore, research continues aimed at studying the mechanisms of COPD developmen
Externí odkaz:
https://doaj.org/article/047d1c323a7748abb86a0067192d14e1
Autor:
Aliaksei G. Kadushkin, Anatoli D. Tahanovich, Lyudmila V. Movchan, Volha V. Dziadzichkina, Olga V. Levandovskaya, Tatsiana V. Shman
Publikováno v:
Research Results in Pharmacology, Vol 8, Iss 1, Pp 59-70 (2022)
Introduction: An antidepressant nortriptyline potentiates glucocorticoid (GC) action with synergistic suppression of inflammatory mediator release, but the precise molecular mechanism is unknown. Materials and methods: Peripheral blood cells from pat
Externí odkaz:
https://doaj.org/article/b83f031b6ab545f3a844f9c3d127ff79
Publikováno v:
Health and Ecology Issues. 19:103-110
Objective. To evaluate the ability of a combination of budesonide and azithromycin to influence the migration of blood monocytes and lymphocytes in patients with chronic obstructive pulmonary disease (COPD).Materials and methods. Peripheral blood mon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9bb30ae509f6997e00fe7674ec0de93f
https://doi.org/10.51523/2708-6011.2022-19-4-14
https://doi.org/10.51523/2708-6011.2022-19-4-14
Autor:
A. G. Kadushkin, A. D. Tahanovich, L. V. Movchan, T. S. Kolesnikova, E. V. Khadasouskaya, T. V. Shman
Publikováno v:
Doklady Biochemistry and Biophysics. 507:307-311
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::07b3199802073a1bbb9598b8908ecb4a
https://doi.org/10.1134/s1607672922050076
https://doi.org/10.1134/s1607672922050076
Autor:
A. D. Tahanovich, N. N. Kauhanka, D. I. Murashka, A. V. Kolb, V. I. Prokhorova, O. V. Got’ko, L. A. Derzhavets
Publikováno v:
Russian Clinical Laboratory Diagnostics. 67:640-646
The possibility of the preoperative level of 42 indicators characterizing the cellular composition and metabolism in blood of patients with stage III lung adenocarcinoma (AC) to predict their relapse-free survival was studied. Blood samples of 451 pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7f5aecf0b701debdf289b9db845c042a
https://doi.org/10.51620/0869-2084-2022-67-11-640-646
https://doi.org/10.51620/0869-2084-2022-67-11-640-646
Publikováno v:
Medical Immunology (Russia). 25:309-318
Currently, no drugs have been identified that could slow progression of chronic obstructive pulmonary disease (COPD), or have a significant impact on patient mortality. Therefore, research continues aimed at studying the mechanisms of COPD developmen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::adc4c757a6bb9c34cb1fe3240cb8e675
https://doi.org/10.15789/1563-0625-eoa-2581
https://doi.org/10.15789/1563-0625-eoa-2581
Publikováno v:
Russian Clinical Laboratory Diagnostics. 67:277-285
Non-small cell lung cancer (NSCLC) occupies the first place in the structure of mortality due to oncological diseases. Late diagnosis worsens the effectiveness of its treatment. There are no informative biomarkers that allow us to judge the prevalenc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de6b009df212ee16791afecc755b2292
https://doi.org/10.51620/0869-2084-2022-67-5-277-285
https://doi.org/10.51620/0869-2084-2022-67-5-277-285
Publikováno v:
Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry. 16:154-163
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ace50bfce4c50043f934fe9a74813d60
https://doi.org/10.1134/s1990750822020081
https://doi.org/10.1134/s1990750822020081
Autor:
A. D. Tahanovich, N. N. Kauhanka, V. I. Prohorova, D. I. Murashko, A. V. Kolb, O. V. Gotko, V. A. Matusevich
Publikováno v:
Proceedings of the National Academy of Sciences of Belarus, Medical series. 19:91-102
Only 60-70 % patients with stage I and 35-40 % with stage II of non-small cell lung cancer (NSCLC) overcome the 5-year survival. The reason for such a high mortality rate is almost always a disease recurrence due to the presence of hidden metastases.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b21fb5b97688e979c4dc3cd22777b583
https://doi.org/10.29235/1814-6023-2022-19-1-91-102
https://doi.org/10.29235/1814-6023-2022-19-1-91-102
Publikováno v:
Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry. 16:45-53
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5f84a726fc8ac16c8cf6eb3e8cafaa38
https://doi.org/10.1134/s1990750822010073
https://doi.org/10.1134/s1990750822010073